Home /
Insights /
Will Life Sciences Companies Face More Scrutiny in 2018?

Will Life Sciences Companies Face More Scrutiny in 2018?

January 9, 2018

Law360

Partners John Bentivoglio and Jennifer Bragg look at key enforcement trends for life sciences companies from 2017 and discuss what to expect in the year ahead.

Stay Connected

@SkaddenArps

September 25 New UDAAP Guidance Is Relevant to OCC-Regulated and Nonregulated Institutions Alike skadden.com/insights/publi…
September 25 We’re pleased to have once again been named Tax Firm of the Year in the Americas — the highest honor — and in five… twitter.com/i/web/status/1…
September 25 SEC Adopts Amendments to Shareholder Proposal Rules skadden.com/insights/publi…